Trumping Science: Part III

Scientists criticize unconfirmed reports that President-elect Donald Trump has asked Robert Kennedy Jr., an anti-vaccine activist, to investigate vaccine safety.

Written byJoshua A. Krisch
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PIXABAY, DFUHLERTPresident-elect Donald Trump discussed vaccines with the prominent anti-vaccine activist Robert Kennedy Jr. on Tuesday (January 10) and, according to Kennedy, asked him to “chair a commission on vaccination safety and scientific integrity.”

Although the Trump transition team has since denied asking Kennedy to chair a commission, the rumor stoked fears among scientists of potential vaccine skepticism in the White House—fears that are not unfounded, given that Trump tweeted in 2014: “Healthy young child goes to doctor, gets pumped with massive shot of many vaccines, doesn’t feel good and changes—AUTISM. Many such cases!”

The American Academy of Pediatrics (AAP) responded to the rumor of Kennedy’s appointment almost immediately. “Vaccines are safe. Vaccines are effective. Vaccines save lives,” Fernando Stein and Karen Remley of the AAP wrote in a statement. “We stand ready to work with the White House and the federal government to share the extensive scientific evidence demonstrating the safety of vaccines, including the recommended schedule.”

Others ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies